+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Domperidone"

Gastroparesis Global Market Report 2024 - Product Thumbnail Image

Gastroparesis Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Diabetic Gastroparesis Treatment Global Market Report 2024 - Product Thumbnail Image

Diabetic Gastroparesis Treatment Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
Global Gastroparesis Drugs Market - Product Thumbnail Image

Global Gastroparesis Drugs Market

  • Report
  • March 2024
  • 200 Pages
  • Global
From
From
From
From
From
  • 9 Results (Page 1 of 1)
Loading Indicator

Domperidone is a drug used to treat gastrointestinal disorders, such as nausea, vomiting, and reflux. It is a dopamine antagonist, meaning it works by blocking the action of dopamine in the brain. It is available in both oral and intravenous forms. Domperidone is used to treat symptoms of gastroesophageal reflux disease (GERD), such as heartburn, regurgitation, and difficulty swallowing. It is also used to treat nausea and vomiting caused by certain medications, such as chemotherapy. Domperidone is a widely used drug in the gastrointestinal market. It is available in many countries, including the United States, Canada, and the United Kingdom. It is also available in generic form, which is often less expensive than the brand-name version. In the gastrointestinal market, domperidone is often used in combination with other drugs, such as proton pump inhibitors, to treat GERD. It is also used to treat nausea and vomiting caused by certain medications, such as chemotherapy. Companies in the domperidone market include Janssen Pharmaceuticals, Teva Pharmaceuticals, and Mylan Pharmaceuticals. Show Less Read more